RBC Capital Reiterates Outperform Rating on JPMorgan Chase & Co. (JPM)
RBC Capital reiterated its Outperform rating on JPMorgan Chase & Co. (NYSE:JPM) on October 14, 2026.
Read moreReal-time context
Upgrades, downgrades, initiations, and price-target changes.
RBC Capital reiterated its Outperform rating on JPMorgan Chase & Co. (NYSE:JPM) on October 14, 2026.
Read moreMorgan Stanley reiterated its Equal-Weight rating on JPMorgan Chase & Co. (NYSE:JPM) on October 14, 2026.
Read moreTruist Securities reiterated its Hold rating on JPMorgan Chase & Co. (NYSE:JPM) on October 14, 2026.
Read moreGuggenheim reiterated its Buy rating on Meta Platforms, Inc. (NASDAQ:META) on October 14, 2026.
Read moreGoldman Sachs reiterated its Buy rating on Meta Platforms, Inc. (NASDAQ:META) on October 14, 2026.
Read moreUBS reiterated its Buy rating on Meta Platforms, Inc. (NASDAQ:META) on October 14, 2026.
Read moreUBS reiterated its Neutral rating on Alphabet Inc. (NASDAQ:GOOG) on October 14, 2026.
Read moreUBS reiterated its Neutral rating on Alphabet Inc. (NASDAQ:GOOGL) on October 14, 2026.
Read moreBaird analysts upgraded Bank of America Corporation (NYSE:BAC) from Neutral to Outperform on October 15, 2026.
Read moreDeutsche Bank analysts upgraded Walmart Inc. (NASDAQ:WMT) from Hold to Buy on October 15, 2026.
Read moreBaird analysts upgraded Bank of America Corporation PFD SER B 7% (OTC:BACRP) from Neutral to Outperform on October 15, 2026.
Read moreWilliam Blair analysts initiated coverage on Jasper Therapeutics, Inc. (NASDAQ:JSPR) with a rating of Outperform on October 14, 2026.
Read moreRBC Capital reiterated its Outperform rating on Infinity Natural Resources, Inc. (NYSE:INR) on October 14, 2026.
Read moreStifel analysts initiated coverage on Innovative Industrial Properties, Inc. (NYSE:IIPR) with a rating of Buy on October 14, 2026.
Read moreJP Morgan analysts initiated coverage on Arcus Biosciences, Inc. (NYSE:RCUS) with a rating of Overweight on October 14, 2026.
Read moreWilliam Blair analysts initiated coverage on Marex Group plc Ordinary Shares (NASDAQ:MRX) with a rating of Outperform on October 14, 2026.
Read moreNeedham reiterated its Buy rating on Liquidia Corporation (NASDAQ:LQDA) on October 14, 2026.
Read moreBTIG analysts upgraded Liquidia Corporation (NASDAQ:LQDA) from Neutral to Buy on October 14, 2026.
Read moreWells Fargo reiterated its Equal-Weight rating on Liquidia Corporation (NASDAQ:LQDA) on October 14, 2026.
Read moreWedbush reiterated its Outperform rating on Beam Therapeutics Inc. (NASDAQ:BEAM) on October 14, 2026.
Read more